Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 40.62% is 228% above its 5-year average of -31.73%, near the high end of its 5-year range (-115.01%–43.43%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.52% above its 12-month average of 37.78%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 40.62%.
RETURN ON EQUITY (ROE)
40.62%
RETURN ON EQUITY (ROE) AVG TTM
37.78%
RETURN ON EQUITY (ROE) AVG 3Y
-22.05%
RETURN ON EQUITY (ROE) AVG 5Y
-31.73%
RETURN ON EQUITY (ROE) AVG 10Y
-46.78%
RETURN ON EQUITY (ROE) AVG 15Y
-52.86%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+7.52%
CURRENT VS 3Y AVG
+284.18%
CURRENT VS 5Y AVG
+228.00%
CURRENT VS 10Y AVG
+186.83%
CURRENT VS 15Y AVG
+176.83%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+196.68%
vs the sector median at left
CorMedix Inc.
Market Cap
$570.35M
Return on Equity (ROE)
40.62%
TTM Avg
37.78%
3Y Avg
-22.05%
5Y Avg
-31.73%
Market Cap
$577.78M
Return on Equity (ROE)
N/A
TTM Avg
161.13%
3Y Avg
93.89%
5Y Avg
96.07%
Market Cap
$561.67M
Return on Equity (ROE)
-26.37%
TTM Avg
-3503.18%
3Y Avg
-1722.33%
5Y Avg
3198.08%
Market Cap
$560.00M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$583.51M
Return on Equity (ROE)
-11.56%
TTM Avg
-11.05%
3Y Avg
-6.83%
5Y Avg
-8.10%
Market Cap
$585.90M
Return on Equity (ROE)
-8.42%
TTM Avg
-4.61%
3Y Avg
-3.17%
5Y Avg
11.46%
Market Cap
$547.30M
Return on Equity (ROE)
-13.64%
TTM Avg
-19.13%
3Y Avg
-73.22%
5Y Avg
-63.52%
Market Cap
$594.45M
Return on Equity (ROE)
-21.51%
TTM Avg
-20.05%
3Y Avg
-35.91%
5Y Avg
-26.18%
Market Cap
$601.84M
Return on Equity (ROE)
N/A
TTM Avg
-4.73%
3Y Avg
76.70%
5Y Avg
93.92%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CorMedix Inc. (CRMD) | $570.35M | 40.62% | 37.78% | -22.05% | -31.73% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $577.78M | N/A | 161.13% | 93.89% | 96.07% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.67M | -26.37% | -3503.18% | -1722.33% | 3198.08% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| OrthoPediatrics Corp. (KIDS)vs › | $583.51M | -11.56% | -11.05% | -6.83% | -8.10% |
| Fulgent Genetics, Inc. (FLGT)vs › | $585.90M | -8.42% | -4.61% | -3.17% | 11.46% |
| Monopar Therapeutics Inc. (MNPR)vs › | $547.30M | -13.64% | -19.13% | -73.22% | -63.52% |
| AngioDynamics, Inc. (ANGO)vs › | $594.45M | -21.51% | -20.05% | -35.91% | -26.18% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $601.84M | N/A | -4.73% | 76.70% | 93.92% |
| Shattuck Labs, Inc. (STTK)vs › | $539.41M | -24.90% | -76.97% | -68.04% | -50.09% |
ROE
40.6%
ROA
20.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 40.62% |
| 2026-03-31 | 41.42% |
| 2025-12-31 | 40.23% |
| 2025-09-30 | 43.43% |
| 2025-06-30 | 23.19% |
| 2025-03-31 | 14.95% |
| 2024-12-31 | -21.18% |
| 2024-09-30 | -78.60% |
| 2024-06-30 | -115.01% |
| 2024-03-31 | -86.60% |
| 2023-12-31 | -66.06% |
| 2023-09-30 | -47.83% |
| 2023-06-30 | -75.23% |
| 2023-03-31 | -61.63% |
| 2022-12-31 | -53.95% |
| 2022-09-30 | -52.01% |
| 2022-06-30 | -50.21% |
| 2022-03-31 | -46.82% |
| 2021-12-31 | -44.92% |
| 2021-09-30 | -38.22% |
| 2021-06-30 | -31.92% |
| 2021-03-31 | -29.49% |
| 2020-12-31 | -49.81% |
| 2020-09-30 | -61.64% |
| 2020-06-30 | -107.50% |
| 2020-03-31 | -77.91% |
| 2019-09-30 | -31.28% |
| 2019-03-31 | -131.86% |
| 2017-09-30 | -300.72% |
| 2017-06-30 | -183.97% |
| 2017-03-31 | -253.63% |
| 2016-12-31 | -138.33% |
| 2016-09-30 | -92.98% |
| 2016-06-30 | -62.96% |
| 2016-03-31 | -55.44% |
| 2015-12-31 | -53.47% |
| 2015-09-30 | -45.44% |
| 2015-06-30 | -45.81% |
| 2015-03-31 | -121.61% |
| 2014-12-31 | -562.76% |
| 2014-09-30 | -388.06% |
| 2011-12-31 | -542.75% |
| 2011-06-30 | -227.17% |
| 2011-03-31 | -112.75% |
| 2010-12-31 | -150.31% |
| 2010-09-30 | -158.86% |
| 2010-06-30 | -140.40% |
| 2010-03-31 | -129.67% |
